K874106 is an FDA 510(k) clearance for the GLANDOSANE (SALIVART) SYNTHETIC SALIVA. Classified as Saliva, Artificial (product code LFD).
Submitted by Fresenius USA, Inc. (Germany, DE). The FDA issued a Cleared decision on April 15, 1988 after a review of 189 days - an extended review cycle.
This device falls under the Dental FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.
View all Fresenius USA, Inc. devices